Blepharospasm Completed Phase 2 Trials for Botulinum toxin type A (DB00083)

Also known as: Spasm eyelid / Eyelid twitching

IndicationStatusPhase
DBCOND0001075 (Blepharospasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00234507Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential BlepharospasmTreatment